Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Fox RJ, Cree BAC, de Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Montalban X, Weinstock-Guttman B, Singh CM, Altincatal A, Belviso N, Avila RL, Ho PR, Su R, Engle R, Sangurdekar D, de Moor C, Fisher E, Kieseier BC, Rudick RA. Fox RJ, et al. Among authors: kieseier bc. Neurology. 2024 May 14;102(9):e209357. doi: 10.1212/WNL.0000000000209357. Epub 2024 Apr 22. Neurology. 2024. PMID: 38648580 Clinical Trial.
Mitoxantrone in multiple sclerosis.
Neuhaus O, Kieseier BC, Hartung HP. Neuhaus O, et al. Among authors: kieseier bc. Adv Neurol. 2006;98:293-302. Adv Neurol. 2006. PMID: 16400840 Review. No abstract available.
Treatment and treatment trials in multiple sclerosis.
Kieseier BC, Wiendl H, Hemmer B, Hartung HP. Kieseier BC, et al. Curr Opin Neurol. 2007 Jun;20(3):286-93. doi: 10.1097/WCO.0b013e3281568b80. Curr Opin Neurol. 2007. PMID: 17495622 Review.
Atacicept: targeting B cells in multiple sclerosis.
Hartung HP, Kieseier BC. Hartung HP, et al. Among authors: kieseier bc. Ther Adv Neurol Disord. 2010 Jul;3(4):205-16. doi: 10.1177/1756285610371146. Ther Adv Neurol Disord. 2010. PMID: 21179612 Free PMC article.
Neutralizing antibodies in interferon beta treated patients with multiple sclerosis: knowing what to do now : Commentary to: 10.1007/s00415-010-5844-5 "One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients" by S. Malucchi et al.
Menge T, Hartung HP, Kieseier BC. Menge T, et al. Among authors: kieseier bc. J Neurol. 2011 May;258(5):904-7. doi: 10.1007/s00415-011-5941-0. J Neurol. 2011. PMID: 21340521 No abstract available.
356 results